CRBU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $1.22

Market Cap (MRQ) $129M

P/E (TTM) -1.1

EPS (TTM) $-1.08

Revenue (TTM) $10M

ROE (TTM) -78.3%

52W Range $1–$4

CRBU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$11M

2019-12-31 → 2025-12-31

EPS$-1.59

2021-12-31 → 2025-12-31

Free Cash Flow$-112M

2021-12-31 → 2025-12-31

Net margin-1030.4%

2021-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	CRBU	5Y avg	Peer Median	Verdict
P/E (TTM)	-1.15Y avg ≈-3.4	≈-3.4	·	·
P/S (TTM)	12.95Y avg ≈33.1	≈33.1	40.4	Undervalued
P/B (MRQ)	1.35Y avg ≈1.4	≈1.4	2.4	Undervalued
Price / FCF (TTM)	-1.45Y avg ≈-7.5	≈-7.5	·	·
Price / Cash Flow (TTM)	-1.45Y avg ≈-8.0	≈-8.0	·	·
Price / Tangible Book	1.05Y avg ≈1.4	≈1.4	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	CRBU	5Y avg	Peer Median	Verdict
Operating Margin (TTM)	-1090.9%5Y avg ≈-959.8%	≈-959.8%	-3077.6%	Top tier
EBITDA Margin (TTM)	-1065.1%5Y avg ≈-939.0%	≈-939.0%	-3077.6%	Top tier
Pretax Margin	-1332.3%5Y avg ≈-906.2%	≈-906.2%	-3779.8%	Top tier
Net Profit Margin (TTM)	-1030.4%5Y avg ≈-906.1%	≈-906.1%	-3650.4%	Top tier
ROA (TTM)	-56.9%5Y avg ≈-35.7%	≈-35.7%	-66.8%	In line
ROE (TTM)	-78.3%5Y avg ≈-46.8%	≈-46.8%	-108.3%	In line
ROIC	-121.0%5Y avg ≈-54.2%	≈-54.2%	-98.3%	Below avg

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	CRBU	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		6.55Y avg ≈9.8	≈9.8	4.2	Strong liquidity
Quick Ratio		0.55Y avg ≈2.9	≈2.9	1.7	Low liquidity

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	CRBU	5Y avg	Peer Median	Verdict
Revenue YoY	11.7%5Y avg ≈22.3%	≈22.3%	·	·
Revenue CAGR 3Y	-7.0%5Y avg ≈11.7%	≈11.7%	·	·
Revenue CAGR 5Y	-2.0%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	CRBU	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-1.595Y avg ≈$-1.67	≈$-1.67	·	·
Revenue / Share	$0.125Y avg ≈$0.23	≈$0.23	·	·
Cash Flow / Share	$-1.195Y avg ≈$-1.37	≈$-1.37	·	·
Cash / Share	$0.135Y avg ≈$1.17	≈$1.17	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	CRBU	5Y avg	Peer Median	Verdict
Asset Turnover	0.05Y avg ≈0.0	≈0.0	0.0	Top tier
Receivables Turnover	66.85Y avg ≈69.5	≈69.5	4.7	Top tier
Revenue / Employee	≈$115.0K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 5.8%

Next Report Nov 09, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 13, 2026	$-0.24	$-0.32	25.7%
March 31, 2026		$-0.26	$-0.32	19.8%
Dec. 31, 2025		$-0.28	$-0.32	11.4%
Sept. 30, 2025		$-0.30	$-0.37	18.4%
June 30, 2025		$-0.58	$-0.40	-45.1%
March 31, 2025		$-0.43	$-0.45	4.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 15

Metric	2025	2024	2023	2022	2021	2020
Revenue	$11M	$10M	$34M	$14M	$10M	$12M
R&D Expense	$109M	$130M	$112M	$82M	$52M	$34M
SG&A Expense	$38M	$46M	$38M	$38M	$24M	$14M
Operating Expenses	$160M	$177M	$151M	$120M	$77M	$48M
Operating Income	$-148M	$-167M	$-116M	$-106M	$-67M	$-36M
Interest Expense	·	·	·	·	$8.0K	$20.0K
Other Non-op	$-331.0K	$18M	$14M	$7M	$377.0K	$-3.0K
Pretax Income	$-149M	$-149M	$-102M	$-99M	$-67M	$-36M
Income Tax	$-550.0K	$-9.0K	$193.0K	$70.0K	$321.0K	$-2M
Net Income	$-148M	$-149M	$-102M	$-99M	$-67M	$-34M
EPS (Basic)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·
EPS (Diluted)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·
Shares (Basic)	93,389,283	90,317,925	73,807,597	60,801,133	31,663,243	·
Shares (Diluted)	93,389,283	90,317,925	73,807,597	60,801,133	31,663,243	·
EBITDA	$-145M	$-163M	$-113M	$-105M	$-66M	·

Balance Sheet 23

Metric	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$12M	$16M	$51M	$58M	$240M	$16M
Short-term Investments	·	·	·	·	$135M	$0
Receivables	$69.0K	$265.0K	$148.0K	$202.0K	$1M	$150.0K
Prepaid Expense	$3M	$7M	$6M	$8M	$7M	$3M
Current Assets	$145M	$219M	$339M	$260M	$391M	$24M
PP&E (Net)	$7M	$19M	$18M	$11M	$5M	$4M
PP&E (Gross)	$20M	$32M	$27M	$16M	$9M	$7M
Accum. Depreciation	$14M	$13M	$9M	$6M	$4M	$3M
Other Non-current Assets	$2M	$6M	$2M	$2M	$975.0K	$612.0K
Total Assets	$175M	$313M	$432M	$374M	$442M	$36M
Accounts Payable	$6M	$2M	$3M	$1M	$4M	$3M
Accrued Liabilities	$17M	$24M	$21M	$16M	$13M	$9M
Current Liabilities	$25M	$31M	$28M	$28M	$26M	$12M
Capital Leases	$26M	$25M	$26M	$27M	$0	·
Deferred Tax	$0	$548.0K	$557.0K	$381.0K	$476.0K	$155.0K
Total Liabilities	$53M	$60M	$64M	$73M	$55M	$18M
Common Stock	$9.0K	$9.0K	$8.0K	$6.0K	$6.0K	$1.0K
Paid-in Capital	$719M	$701M	$668M	$500M	$486M	$7M
Retained Earnings	$-597M	$-448M	$-299M	$-197M	$-98M	$-31M
AOCI	$103.0K	$255.0K	$30.0K	$-2M	$-135.0K	$0
Stockholders' Equity	$122M	$253M	$368M	$301M	$388M	$-23M
Liabilities + Equity	$175M	$313M	$432M	$374M	$442M	$36M
Shares Outstanding	95,143,690	92,378,577	88,448,948	61,029,184	60,263,158	9,710,829

Cash Flow 14

Metric	2025	2024	2023	2022	2021	2020
D&A	$4M	$4M	$4M	$2M	$984.0K	$900.0K
Stock-based Comp	$13M	$17M	$14M	$12M	$3M	$1M
Deferred Tax	$-551.0K	$-10.0K	$178.0K	$-95.0K	$320.0K	$-919.0K
Other Non-cash	$21M	$-10M	$-9M	$-5M	$30M	·
Operating Cash Flow	$-111M	$-138M	$-93M	$-91M	$-33M	$-33M
CapEx	$1M	$5M	$12M	$6M	$2M	$317.0K
Investing Cash Flow	$102M	$87M	$-68M	$-93M	$-176M	$6M
Stock Issued	$4M	$15M	$1M	$0	·	·
Net Stock Activity	$4M	$15M	$1M	·	·	·
Financing Cash Flow	$5M	$17M	$154M	$2M	$433M	$2M
Net Change in Cash	$-4M	$-35M	$-7M	$-182M	$225M	$-25M
Taxes Paid	·	$0	$170.0K	$0	$11.0K	$21.0K
Free Cash Flow	$-112M	$-143M	$-105M	$-97M	$-35M	·
Levered FCF	·	·	·	·	$-35M	·

Profitability 7

Metric	2025	2024	2023	2022	2021	2020
Operating Margin	-1329.4%	-1667.2%	-336.6%	-768.2%	-697.8%	·
Net Margin	-1327.4%	-1491.9%	-296.1%	-717.8%	-697.3%	·
Pretax Margin	-1332.3%	-1492.0%	-295.5%	-717.3%	-693.9%	·
EBITDA Margin	-1296.7%	-1627.9%	-326.4%	-756.5%	-687.6%	·
ROA	-60.6%	-40.0%	-25.3%	-24.4%	-28.0%	·
ROE	-102.8%	-55.8%	-26.6%	-31.8%	-16.9%	·
ROIC	-121.0%	-65.9%	-31.6%	-35.4%	-17.3%	·

Liquidity & Solvency 3

Metric	2025	2024	2023	2022	2021	2020
Current Ratio	5.7	7.2	12.0	9.3	15.1	·
Quick Ratio	0.5	0.5	1.8	2.1	9.4	·
Interest Coverage	·	·	·	·	-8372.4	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.0	0.1	0.0	0.0	·
Receivables Turnover		66.8	48.4	197.0	20.4	14.7	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020
Book Value / Share	$1.28	$2.74	$4.17	$4.93	$6.44	·
Revenue / Share	$0.12	$0.11	$0.47	$0.23	·	·
Cash Flow / Share	$-1.19	$-1.53	$-1.26	$-1.50	·	·
Cash / Share	$0.13	$0.18	$0.58	$0.96	$3.99	·
EPS (TTM)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020
Revenue YoY	11.7%	-71.0%	148.9%	44.3%	-22.4%	·
Revenue CAGR 3Y	-7.0%	1.4%	40.8%	·	·	·
Revenue CAGR 5Y	-2.0%	·	·	·	·	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020
Revenue TTM	$11M	$10M	$34M	$14M	$10M	·
Net Income TTM	$-148M	$-149M	$-102M	$-99M	$-67M	·
Market Cap	$151M	$147M	$507M	$383M	$909M	·
P/E	-1.0	-1.0	-4.2	-3.8	-7.2	·
P/S	13.6	14.7	14.7	27.7	94.7	·
P/B	1.2	0.6	1.4	1.3	2.3	·
P / Tangible Book	1.2	0.6	1.4	1.3	2.3	·
P / Cash Flow	-1.4	-1.1	-5.4	-4.2	-28.0	·
P / FCF	-1.3	-1.0	-4.8	-3.9	-26.3	·
Earnings Yield	-100.0%	-103.8%	-24.1%	-26.1%	-14.0%	·

Income Statement 13

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1M	$2M	$4M	$2M	$3M	$2M	$2M	$2M	$3M	$2M	$4M	$24M	$4M	$4M	$4M	$3M
R&D Expense	$19M	$21M	$24M	$22M	$28M	$36M	$30M	$30M	$35M	$34M	$31M	$29M	$27M	$26M	$26M	$20M
SG&A Expense	$8M	$8M	$9M	$9M	$10M	$10M	$10M	$10M	$11M	$15M	$10M	$10M	$10M	$9M	$9M	$10M
Operating Expenses	$27M	$29M	$32M	$32M	$50M	$45M	$41M	$40M	$47M	$48M	$41M	$38M	$37M	$35M	$34M	$30M
Operating Income	$-25M	$-26M	$-28M	$-29M	$-48M	$-43M	$-39M	$-38M	$-44M	$-46M	$-37M	$-15M	$-33M	$-31M	$-31M	$-27M
Other Non-op	$1M	$1M	$1M	$2M	$-7M	$3M	$3M	$4M	$6M	$5M	$3M	$5M	$3M	$3M	$4M	$-110.0K
Income Tax	·	$0	$-550.0K	$0	·	$0	$-9.0K	$0	$0	$0	$193.0K	$0	$0	$0	$70.0K	$0
Net Income	$-24M	$-25M	$-26M	$-28M	$-54M	$-40M	$-35M	$-35M	$-38M	$-41M	$-35M	$-10M	$-30M	$-28M	$-27M	$-27M
EPS (Basic)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.32	$-0.12	$-0.48	$-0.46	$-0.44	$-0.44
EPS (Diluted)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.32	$-0.12	$-0.48	$-0.46	$-0.44	$-0.44
Shares (Basic)	100,985,698	95,861,716	·	93,293,099	93,028,698	92,679,493	·	90,455,900	90,340,932	89,302,937	·	83,783,992	61,417,934	61,186,514	·	60,886,921
Shares (Diluted)	100,985,698	95,861,716	·	93,293,099	93,028,698	92,679,493	·	90,455,900	90,340,932	89,302,937	·	83,783,992	61,417,934	61,186,514	·	60,886,921
EBITDA	$-25M	$-26M	·	$-29M	$-48M	$-42M	·	$-38M	$-44M	$-45M	·	$-15M	·	·	·	$-27M

Balance Sheet 22

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$26M	$12M	$12M	$11M	$25M	$29M	$16M	$32M	$38M	$49M	$51M	$104M	$66M	$53M	$58M	$82M
Receivables	$203.0K	$227.0K	$69.0K	$242.0K	$71.0K	$88.0K	$265.0K	$184.0K	$215.0K	$917.0K	$148.0K	$1M	$766.0K	$2M	$202.0K	$397.0K
Prepaid Expense	$2M	$2M	$3M	$5M	$6M	$6M	$7M	$7M	$6M	$7M	$6M	$7M	$6M	$6M	$8M	$9M
Current Assets	$117M	$122M	$145M	$156M	$193M	$217M	$219M	$237M	$271M	$305M	$339M	$351M	$269M	$239M	$260M	$307M
PP&E (Net)	$5M	$6M	$7M	$8M	$8M	$19M	$19M	$20M	$20M	$19M	$18M	$17M	$15M	$13M	$11M	$9M
PP&E (Gross)	$20M	$20M	$20M	$20M	$20M	$33M	$32M	$31M	$31M	$29M	$27M	$25M	$22M	$19M	$16M	$14M
Accum. Depreciation	$15M	$14M	$14M	$13M	$12M	$14M	$13M	$12M	$11M	$10M	$9M	$8M	$7M	$6M	$6M	$5M
Other Non-current Assets	$2M	$2M	$2M	$4M	$4M	$5M	$6M	$5M	$2M	$2M	$2M	$2M	$1M	$1M	$2M	$1M
Total Assets	$143M	$149M	$175M	$195M	$221M	$274M	$313M	$344M	$373M	$407M	$432M	$458M	$350M	$347M	$374M	$399M
Accounts Payable	$3M	$4M	$6M	$4M	$3M	$4M	$2M	$3M	$3M	$6M	$3M	$2M	$4M	$3M	$1M	$1M
Accrued Liabilities	$13M	$14M	$17M	$19M	$21M	$20M	$24M	$25M	$24M	$19M	$21M	$18M	$16M	$13M	$16M	$15M
Current Liabilities	$18M	$20M	$25M	$28M	$29M	$28M	$31M	$32M	$31M	$29M	$28M	$25M	$34M	$27M	$28M	$29M
Capital Leases	$25M	$26M	$26M	$23M	$24M	$24M	$25M	$25M	$26M	$26M	$26M	$26M	$26M	$26M	$27M	$27M
Deferred Tax	·	·	$0	$548.0K	$548.0K	$548.0K	$548.0K	$557.0K	$557.0K	$556.0K	$557.0K	$381.0K	$380.0K	$382.0K	$381.0K	$475.0K
Total Liabilities	$45M	$47M	$53M	$53M	$55M	$56M	$60M	$63M	$62M	$64M	$64M	$59M	$80M	$69M	$73M	$75M
Common Stock	$11.0K	$10.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$8.0K	$8.0K	$6.0K	$6.0K	$6.0K	$6.0K
Paid-in Capital	$744M	$724M	$719M	$712M	$709M	$705M	$701M	$693M	$689M	$684M	$668M	$664M	$525M	$504M	$500M	$496M
Retained Earnings	$-646M	$-622M	$-597M	$-570M	$-542M	$-488M	$-448M	$-413M	$-378M	$-341M	$-299M	$-265M	$-255M	$-225M	$-197M	$-170M
AOCI	$-71.0K	$-23.0K	$103.0K	$93.0K	$40.0K	$167.0K	$255.0K	$789.0K	$-319.0K	$-322.0K	$30.0K	$-981.0K	$-1M	$-730.0K	$-2M	$-2M
Stockholders' Equity	$98M	$102M	$122M	$142M	$166M	$217M	$253M	$281M	$310M	$343M	$368M	$398M	$269M	$278M	$301M	$324M
Liabilities + Equity	$143M	$149M	$175M	$195M	$221M	$274M	$313M	$344M	$373M	$407M	$432M	$458M	$350M	$347M	$374M	$399M
Shares Outstanding	105,995,653	96,951,234	95,143,690	93,468,038	93,123,239	93,004,602	92,378,577	90,552,687	90,362,771	90,314,501	88,448,948	88,430,609	66,100,039	61,323,523	61,029,184	60,986,936

Cash Flow 13

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$625.0K	$649.0K	$682.0K	$631.0K	$1M	$1M	$1M	$1M	$856.0K	$710.0K	$740.0K	$2M	$617.0K	$589.0K	$506.0K	$450.0K
Stock-based Comp	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$4M	$5M	$4M	$4M	$3M	$4M	$3M	$3M	$3M
Restructuring	·	·	·	·	·	·	·	$600.0K	·	·	·	·	·	·	·	·
Other Non-cash	·	$-5M	·	·	·	$-2M	·	·	·	$-667.0K	·	·	·	·	·	·
Operating Cash Flow	$-23M	$-27M	$-21M	$-25M	$-28M	$-37M	$-35M	$-33M	$-33M	$-37M	$-21M	$-29M	$-15M	$-28M	$-25M	$-22M
CapEx	$1.0K	$72.0K	$-216.0K	$115.0K	$418.0K	$1M	$518.0K	$673.0K	$2M	$1M	$2M	$5M	$3M	$2M	$2M	$1M
Investing Cash Flow	$19M	$24M	$18M	$11M	$24M	$49M	$16M	$27M	$21M	$23M	$-31M	$-68M	$11M	$21M	$1M	$-8M
Stock Issued	$18M	$2M	$4M	$0	$0	$0	$4M	$0	$0	$11M	$0	$-1.0K	$-115.0K	$1M	$0	$0
Net Stock Activity	·	$2M	·	·	·	$0	·	·	·	$11M	·	·	·	·	·	·
Financing Cash Flow	$18M	$3M	$4M	$277.0K	$6.0K	$468.0K	$4M	$244.0K	$132.0K	$12M	$-43.0K	$135M	$18M	$2M	$127.0K	$654.0K
Net Change in Cash	$14M	$-303.0K	$1M	$-14M	$-4M	$13M	$-16M	$-6M	$-12M	$-2M	$-53M	$38M	$13M	$-6M	$-24M	$-30M
Taxes Paid	·	·	·	·	·	·	·	$0	·	·	$0	$0	·	·	$0	$0
Free Cash Flow	·	$-27M	·	·	·	$-38M	·	·	·	$-39M	·	·	·	·	·	·

Profitability 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1690.4%	-1096.4%	·	-1337.6%	-1784.0%	-1823.8%	·	-1889.2%	-1255.8%	-1893.9%	·	-61.8%	·	·	·	-803.4%
Net Margin	-1619.9%	-1046.5%	·	-1253.3%	-2028.4%	-1699.6%	·	-1713.6%	-1088.2%	-1697.6%	·	-42.3%	·	·	·	-806.8%
EBITDA Margin	-1690.4%	-1069.3%	·	-1337.6%	-1784.0%	-1774.2%	·	-1889.2%	-1255.8%	-1864.6%	·	-61.8%	·	·	·	-803.4%
ROA	-13.4%	-11.9%	·	-10.2%	-18.2%	-11.8%	·	-8.6%	-10.4%	-10.9%	·	-2.3%	·	·	·	-6.2%
ROE	-18.4%	-15.7%	·	-13.0%	-22.7%	-14.3%	·	-10.2%	-13.0%	-13.3%	·	-2.8%	·	·	·	-7.3%

Liquidity & Solvency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.5	6.2	·	5.5	6.7	7.6	·	7.4	8.8	10.5	·	14.3	·	·	·	10.7
Quick Ratio		1.5	0.6	·	0.4	0.9	1.0	·	1.0	1.2	1.7	·	4.3	·	·	·	2.9

Efficiency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.1	·	·	·	0.0
Receivables Turnover		10.9	15.2	·	10.3	18.7	4.7	·	3.1	7.1	2.0	·	30.9	·	·	·	6.8

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.93	$1.05	·	$1.52	$1.78	$2.34	·	$3.11	$3.44	$3.80	·	$4.50	·	·	·	$5.31
Revenue / Share	$0.01	$0.03	·	$0.02	$0.03	$0.03	·	$0.02	$0.04	$0.03	·	$0.28	·	·	·	$0.05
Cash Flow / Share	·	$-0.28	·	·	·	$-0.40	·	·	·	$-0.42	·	·	·	·	·	·
Cash / Share	$0.25	$0.12	·	$0.12	$0.27	$0.32	·	$0.35	$0.42	$0.55	·	$1.18	·	·	·	$1.35
EPS (TTM)	$-1.08	$-1.42	·	$-1.70	$-1.78	$-1.62	·	$-1.58	$-1.32	$-1.38	·	$-1.50	$-1.82	$-1.66	·	$-1.11

Valuation (TTM) 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$10M	$11M	·	$9M	$9M	$10M	·	$11M	$33M	$33M	·	$35M	$15M	$14M	·	$13M
Net Income TTM	$-103M	$-133M	·	$-157M	$-164M	$-148M	·	$-148M	$-123M	$-115M	·	$-95M	$-111M	$-100M	·	$-91M
Market Cap	$187M	$184M	·	$218M	$117M	$85M	·	$177M	$148M	$464M	·	$423M	·	·	·	$643M
P/E	-1.6	-1.3	·	-1.4	-0.7	-0.6	·	-1.2	-1.2	-3.7	·	-3.2	-2.3	-3.2	·	-9.5
P/S	18.6	16.4	·	23.4	12.9	8.6	·	15.5	4.5	13.9	·	12.2	·	·	·	50.6
P/B	1.9	1.8	·	1.5	0.7	0.4	·	0.6	0.5	1.4	·	1.1	·	·	·	2.0
P / Tangible Book	1.9	1.8	·	1.5	0.7	0.4	·	0.6	0.5	1.4	·	1.1	1.0	1.2	·	2.0
P / Cash Flow	·	-6.8	·	·	·	-2.3	·	·	·	-12.5	·	·	·	·	·	·
Earnings Yield	-61.4%	-74.7%	·	-73.0%	-141.3%	-177.4%	·	-80.6%	-80.5%	-26.9%	·	-31.4%	-42.8%	-31.3%	·	-10.5%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$11M	$10M	$34M	$14M	$10M
Operating Margin %	-1329.4%	-1667.2%	-336.6%	-768.2%	-697.8%
Net Income	$-148M	$-149M	$-102M	$-99M	$-67M
Diluted EPS	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Current Ratio	5.7	7.2	12.0	9.3	15.1
Quick Ratio	0.5	0.5	1.8	2.1	9.4

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-112M	$-143M	$-105M	$-97M	$-35M

Institutional owners (13F) 148 filers · $89.6M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 148

Value held $89.6M

New positions 26

Exited positions 22

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
26 (-4 vs prior Q)	22 (+11 vs prior Q)	45 (+14 vs prior Q)	28 (-10 vs prior Q)	+10.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
BlackRock, Inc.	$13,755,883	7,815,843	15.36%	Shares
Pfizer Inc	$7,879,924	4,690,431	8.80%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$7,407,080	4,208,568	8.27%	Shares
VANGUARD GROUP INC	$6,843,676	4,304,198	7.64%	Shares
MACKENZIE FINANCIAL CORP	$6,425,401	3,650,796	7.17%	Shares
RENAISSANCE TECHNOLOGIES LLC	$4,881,439	2,773,545	5.45%	Shares
Kynam Capital Management, LP	$4,405,812	2,503,302	4.92%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$4,180,624	2,374,894	4.67%	Shares
STATE STREET CORP	$2,873,929	1,632,914	3.21%	Shares
BANK OF AMERICA CORP /DE/	$2,483,287	1,410,958	2.77%	Shares
TWO SIGMA INVESTMENTS, LP	$1,841,451	1,046,279	2.06%	Shares
TWO SIGMA ADVISERS, LP	$1,773,963	1,115,700	1.98%	Shares
DIMENSIONAL FUND ADVISORS LP	$1,716,629	975,327	1.92%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1,365,424	775,809	1.52%	Shares
FMR LLC	$1,279,722	727,115	1.43%	Shares
NORTHERN TRUST CORP	$1,254,819	712,965	1.40%	Shares
MAVERICK CAPITAL LTD	$1,148,474	652,542	1.28%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$1,080,290	613,801	1.21%	Shares
VANGUARD FIDUCIARY TRUST CO	$1,067,243	606,388	1.19%	Shares
Qube Research & Technologies Ltd	$960,529	545,755	1.07%	Shares
UBS Group AG	$910,573	517,371	1.02%	Shares
72 Investment Holdings, LLC	$834,358	474,067	0.93%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$723,323	410,979	0.81%	Shares
MARSHALL WACE, LLP	$661,205	375,686	0.74%	Shares
Green Alpha Advisors, LLC	$641,210	364,324	0.72%	Shares
PFM Health Sciences, LP	$624,249	354,687	0.70%	Shares
GOLDMAN SACHS GROUP INC	$568,260	322,875	0.63%	Shares
Invesco Ltd.	$529,966	301,117	0.59%	Shares
WELLS FARGO & COMPANY/MN	$525,035	298,315	0.59%	Shares
XTX Topco Ltd	$473,716	269,157	0.53%	Shares
Bruce & Co., Inc.	$440,000	250,000	0.49%	Shares
Man Group plc	$422,516	240,066	0.47%	Shares
Bank of New York Mellon Corp	$391,706	222,560	0.44%	Shares
MILESTONE ASSET MANAGEMENT, LLC	$352,150	200,085	0.39%	Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$305,140	173,375	0.34%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$291,129	165,414	0.33%	Shares
Susquehanna Portfolio Strategies, LLC	$279,131	158,597	0.31%	Shares
Graham Capital Management, L.P.	$274,409	155,914	0.31%	Shares
AMERICAN CENTURY COMPANIES INC	$247,421	140,580	0.28%	Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$232,320	132,000	0.26%	Shares
Nuveen, LLC	$217,388	123,516	0.24%	Shares
CITADEL ADVISORS LLC	$217,008	123,300	0.24%	Call option
Cubist Systematic Strategies, LLC	$216,135	92,762	0.24%	Shares
LPL Financial LLC	$216,082	122,774	0.24%	Shares
MORGAN STANLEY	$213,523	121,320	0.24%	Shares
NANO CAP NEW MILLENNIUM GROWTH FUND L P	$206,800	117,500	0.23%	Shares
DEUTSCHE BANK AG\	$157,652	89,575	0.18%	Shares
Quadrature Capital Ltd	$156,603	88,979	0.17%	Shares
CANADA PENSION PLAN INVESTMENT BOARD	$142,736	81,100	0.16%	Shares
Keystone Financial Group	$142,252	80,825	0.16%	Shares

Show all 148 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 filings	April 25, 2025	5.00%	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 18 insiders · 9 officers · 7 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Rachel E. Haurwitz	President and CEO	Feb. 20, 2026 A	447,150	0	$0
Sriram Ryali	Chief Financial Officer	Feb. 20, 2026 A	72,360	0	$0
Jason O'Byrne	Chief Financial Officer	Feb. 20, 2024 A	59,224	0	$0
Timothy P Kelly	Chief Technology Officer	Feb. 25, 2026 S	73,125	2	$-18,188
Tina M. Albertson	Chief Medical Officer	Feb. 20, 2026 A	68,523	1	$-2,089
Ruhi Ahmad Khan	Chief Business Officer	Feb. 20, 2026 A	104,998	1	$-13,598
Steven Kanner	Chief Scientific Officer	Feb. 20, 2025 A	431,556	0	$0
Ryan Fischesser	VP of Finance and Controller	Nov. 20, 2024 A	118,854	0	$0
Syed Ali-Aamir Rizvi	Chief Medical Officer	Feb. 21, 2023 A	59,373	0	$0
Dara Richardson-Heron	Director	Feb. 20, 2026 A	·	0	$0
Ran Zheng	Director	Feb. 20, 2026 A	·	0	$0
Nancy Whiting	Director	Feb. 20, 2026 A	·	0	$0
David Lee Johnson	Director	Feb. 20, 2026 A	·	0	$0
Natalie Sacks	Director	Feb. 20, 2026 A	·	0	$0
Scott Braunstein	Director	Feb. 20, 2026 A	·	0	$0
Barbara G Mcclung	·	Feb. 20, 2026 A	481,564	1	$-13,598
Andrew Guggenhime	·	Feb. 20, 2026 A	·	0	$0
FMR LLC	·	July 27, 2021 C	1,464,775	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 15 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
OMFS · Invesco Exchange-Traded Self-Indexe…	0.08%	164,575 SH	Oct. 1, 2026	Daily
IWC · iShares Trust	0.03%	319,257 SH	Sept. 11, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.01%	79,869 SH	Aug. 19, 2026	Daily
IBB · iShares Trust	0.01%	670,052 SH	Sept. 11, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.01%	6,958 SH	Oct. 1, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.01%	134,582 SH	Oct. 1, 2026	Daily
RSSL · Global X Funds	0.00%	43,883 NS	July 31, 2026	N-PORT
IWM · iShares Trust	0.00%	2,250,647 SH	Sept. 11, 2026	Daily
DFAS · Dimensional ETF Trust	0.00%	255,338 NS	July 31, 2026	N-PORT
DFAC · Dimensional ETF Trust	0.00%	74,931 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.00%	1,113,215 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	3,013,973 SH	Aug. 19, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.00%	524,917 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	9,015 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	875,712 SH	Sept. 11, 2026	Daily

CRBU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 13 analysts BUY

Median target $10.00 +719.7%

5 38.5% Strong Buy

7 53.8% Buy

1 7.7% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

7 analysts · 2026-10-02

Mean target $11.86 +871.9%

← Below all targets Current price $1.22

Low$4.00 Mean$11.86 High$32.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
CRBU	$151M	-1.0	11.7%	-1327.4%	-102.8%	·
KRRO	$75M	-0.6	181.5%	-1834.5%	-140.8%	·
OTLK	$57M	-0.6	·	-4416.2%	193.1%	4.0%
FHTX	$306M	-4.6	36.8%	-240.3%	80.2%	·
PMVP	$67M	-0.8	-40.5%	-1226.8%	-63.4%	·
RNA	$10.91B	-14.5	72.1%	-3650.4%	-47.5%	·
SPRB	$120M	-1.7	-51.3%	·	-139.9%	·
TNYA	$154M	-1.2	·	·	-81.2%	·
CBUS	·	-0.6	-14.6%	-3492.3%	-223.0%	·
INO	$120M	-1.0	-70.0%	-130000.0%	-322.8%	·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

CRBU Caribou Biosciences, Inc. - Common Stock

CRBU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

CRBU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Institutional owners (13F) 148 filers · $89.6M total · As of June 30, 2026

Activists & 5%+ owners 1 position

Company insiders 18 insiders · 9 officers · 7 directors

ETF ownership Held by 15 ETFs

CRBU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Peer comparison (GICS sub-industry) Key metrics vs sector peers

My Metrics Your personal watchlist — selected rows from Full Fundamentals